secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0000917520-24-000105
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences names Mojdeh Poul as President & CEO effective Jan 6, 2025
-------------------------------------------------------------------------------

- Mojdeh Poul appointed President & CEO, effective January 6, 2025, succeeding Jan De Witte.
- Poul previously EVP & Group President of 3M's $8.5B global healthcare business.
- Poul to receive base salary of $1.05M, target bonus 125%, and initial equity awards totaling $6.75M.
- Jan De Witte's resignation is part of a previously announced succession plan; no disagreement.
- Stuart Essig to remain Executive Chairman temporarily before returning to non-executive role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/0000917520-24-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/iart-20241104.htm
  HTML page:      https://secwatch.observer/filing/0000917520-24-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer